The authors hypothesize that the DNA repair functions of SIRT6, which are beneficial in the physiological state, work in favor of AML here, and SIRT6 inactivation increases the toxicity of chemotherapy [140]. This evidence concerns the gene SIRT6 and acute myeloid leukemia.